HUMAN Gesellschaft für Biochemica und Diagnostica mbH Revenue and Competitors

Wiesbaden, GER

Location

#322

Growjo Ranking

Medical

Industry

Estimated Revenue & Valuation

  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH's estimated annual revenue is currently $95M per year.(i)
  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH's estimated revenue per employee is $418,678

Employee Data

  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH has 227 Employees.(i)
  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH grew their employee count by 482% last year.

HUMAN Gesellschaft für Biochemica und Diagnostica mbH's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$65.8M15720%N/AN/A
#2
$82.4M1973%N/AN/A
#3
$178M374-32%N/AN/A
#4
$24.6M6535%N/AN/A
#5
$104.2M24921%N/AN/A
#6
$63.4M15122%N/AN/A
#7
$101.4M24219%N/AN/A
#8
$163.2M34322%N/AN/A
#9
$86.2M20620%N/AN/A
#10
$49.3M11828%N/AN/A
Add Company

What Is HUMAN Gesellschaft für Biochemica und Diagnostica mbH?

At HUMAN, our mission is to empower laboratories to fulfill their daily challenges and implement long-term IVD projects to improve patient care. Offering a broad and comprehensive product portfolio with German quality standards, we provide reliable solutions that meet the most diverse local requirements. Worldwide service and supply capabilities as well as close cooperation with our long-standing distribution partners enable us to individually support healthcare professionals in more than 160 countries. All above has made us a recognized global player in the IVD industry over the past half century. Discover HUMAN and see how our solutions help you achieve your objectives. We look forward to seeing you!

keywords:N/A

N/A

Total Funding

227

Number of Employees

$95M

Revenue (est)

482%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.1M28319%N/A
#2
$86.6M31524%N/A
#3
$77.2M35122%N/A
#4
$64.9M35831%N/A
#5
$87.2M62315%N/A